ReviewCancer medicine2026
Exploring the Role of Long Noncoding RNAs in Breast Cancer Progression: A Comprehensive Study on Biomarkers and Therapeutic Approaches.
Review in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAmong the many forms of cancer that plague women all over the globe, breast cancer (BC) is one of the most prevalent kinds. BC is a multifaceted disease that can manifest in many ways depending on the individual.
aimsThe identification of new biomarkers that may be used to diagnose and prognosis of the BC, as well as those that can aid in the creation of novel therapeutic approaches and the understanding of how to regulate multiple pathways in metastasis, may initiate the process of creating novel therapeutic interventions for cancer patients. MATERIALS AND
methodsAccording to data from recent studies, long noncoding RNAs (LncRNAs) contribute to the development of BC via several distinct biochemical mechanisms. Remembering that long LncRNAs are longer than 200 nucleotides and do not encode proteins is essential.
resultsThrough its interaction with the EGF, TGF-β, NF-κB, PI3K/AKT, and p53 pathways, the abnormal production of LncRNA has a substantial impact on the progression of BC.
conclusionsThis research investigates the biological properties of LncRNAs to ascertain their role in regulating cell signaling pathways and the subsequent changes in cell survival, invasion, and proliferation components that characterize BC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.